Jump to content

Lung Cancer Canada requesting our help Re: Nivolumab (Opdivo)


Recommended Posts

HI All- 

Our friends at LCC need our help on immunotherapy 

See below:


Please Share Your Insights on Nivolumab! (Opdivo)

Canada is evaluating nivolumab for public coverage and we need your help. We are looking for patients and caregivers who have had experience with nivolumab in NSCLC. The Pan-Canadian Oncology Drug Review (pCORDR) group is a government organization that decides if nivolumab should receive public coverage. It is an important step to getting access in Canada. Lung Cancer Canada completes the patient and caregiver experience portion of that submission. We are looking for patients and caregivers who have experience with Nivolumab to speak to us either one on one or in a group discussion. It should take no more than 60 minutes of your time. We will work around your availability. You don’t have to be Canadian to participate. pCODR considers the patient experience to be the patient experience. We would need to speak to you by November 10.

Thanks for your help. Please connect with [email protected] if you are able to help!!!!


Link to post
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...